minoxidil has been researched along with Hypertrichosis in 68 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
Hypertrichosis: Excessive hair growth at inappropriate locations, such as on the extremities, the head, and the back. It is caused by genetic or acquired factors, and is an androgen-independent process. This concept does not include HIRSUTISM which is an androgen-dependent excess hair growth in WOMEN and CHILDREN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Topical minoxidil has been used for almost 40 years to treat alopecia." | 9.05 | Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review. ( Atanaskova Mesinkovska, N; Juhasz, M; Michelle, L; Muller Ramos, P; Sharma, AN, 2020) |
| "The effects of minoxidil used in combination with propranolol were assessed in the management of moderate hypertension." | 9.05 | Minoxidil in the management of moderate hypertension. ( Alleyne, GA; Nicholson, GD; Valdes, G; Westerman, RL, 1980) |
| "The effect of the new vasodilator, minoxidil, on blood pressure and plasma renin activity was studied in 21 hypertensive patients: 12 patients with essential and 9 with renal hypertension." | 9.04 | The effect of minoxidil on blood pressure and plasma renin activity in patients with essential and renal hypertension. ( Werning, C, 1976) |
| "Thirteen patients whose hypertension had been resistant to conventional drug therapy, had minoxidil added to their regimen in doses from 5 to 60 mg/day." | 9.04 | Clinical and haemodynamic effects of minoxidil in refractory hypertension. ( Clarkson, AR; Frewin, DB; Jackson, B; Lawrence, JR; Robinson, MA; Wilson, LL; Zacest, R, 1976) |
| " Twenty patients with severe or moderate hypertension were treated with minoxidil for 284 patient-months." | 9.04 | Treatment of severe and moderate hypertension with minoxidil: experience in twenty-eight patients. ( Dunea, G; Mahurkar, SD; Mamdani, B, 1976) |
| "Hypertrichosis has been reported more frequently in females than in males who use minoxidil topical solution (MTS) for the treatment of androgenetic alopecia (AGA)." | 8.82 | Hypertrichosis in females applying minoxidil topical solution and in normal controls. ( Dawber, RP; Rundegren, J, 2003) |
| "We report three cases of severe hypertrichosis in healthy infants, who did not present any type of endocrinological pathology and whose parents used topical minoxidil for the treatment of their baldness." | 7.96 | Severe hypertrichosis in infants due to transdermic exposure to 5% and 7% topical minoxidil. ( Arcangeli, F; Delgado Rubio, A; García Del Monte, J; Lotti, T; Rica Echevarría, I, 2020) |
| "Hypertrichosis is a well-recognized adverse effect of therapy with either oral or topical minoxidil." | 7.79 | Long-pulsed Nd:YAG laser in the treatment of facial hypertrichosis during topical minoxidil therapy. ( Ben Hamida, M; Benmously Mlika, R; Dorbani Ben Thabet, I; Hammami, H; Mokhtar, I; Rouatbi, M, 2013) |
| "Five women affected by androgenetic alopecia developed severe hypertrichosis of the face and limbs after 2-3 months of treatment with 5% topical minoxidil." | 7.69 | Diffuse hypertrichosis during treatment with 5% topical minoxidil. ( Misciali, C; Peluso, AM; Tosti, A; Vincenzi, C, 1997) |
| "Generalized hypertrichosis is a common side-effect of oral minoxidil treatment for hypertension." | 7.69 | Generalized hypertrichosis after treatment with topical minoxidil. ( Bilbao, I; Calderón, MJ; Díaz Pérez, JL; Gardeazabal, J; González, M; Landa, N, 1994) |
| "Minoxidil, a potent peripheral vasodilator, was used concomitantly with other antihypertensive drugs for severe hypertension in three children for 47 to 158 weeks at the dosage of 40 to 50 mg/day." | 7.66 | Rebound hypertension following minoxidil withdrawal. ( Makker, SP; Moorthy, B, 1980) |
| "Minoxidil (6-amino-1,2-dihydro-1-hydroxy-2-imino-4-piperidinopyrimidine), a new substance for the treatment of severe hypertension, is frequently associated with hypertrichosis." | 7.66 | [Hypertrichosis caused by minoxidil]. ( Ryckmanns, F, 1980) |
| "A case of hypertrichosis due to the hypotensive drug minoxidil is described." | 7.66 | Hypertrichosis due to minoxidil. ( Burton, JL; Marshall, A, 1979) |
| "The efficacy and side effects of two potent vasodilatators, namely diazoxide and minoxidil given orally, were compared in 11 patients who had hypertension refractory to conventional drug treatment." | 7.66 | [Comparison of oral diazoxide and minoxidil in refractory hypertension]. ( Glück, Z; Grimm, M; Keusch, G; Meier, A; Minder, I; Reubi, FC; Weidmann, P, 1980) |
| "Minoxidil, a potent vasodilator antihypertensive agent, was given to 14 patients with severe hypertension uncontrolled by conventional agents." | 7.66 | Minoxidil therapy for refractory hypertension and chronic renal failure. ( Hammond, JJ; Kirkendall, WM, 1979) |
| "Minoxidil was used in 25 patients with severe hypertension whose blood pressure (BP) could not be controlled with conventional treatment or who suffered from intolerable side effects during treatment with other drugs." | 7.66 | Clinical experience of long-term treatment with minoxidil in severe arterial hypertension. ( Hagstam, KE; Lundgren, R; Wieslander, J, 1982) |
| " Propranolol and diuretics were given to prevent reflex tachycardia and fluid retention." | 7.65 | Severe hypertension. Treatment with minoxidil. ( Dunea, G; Mahurkar, SD; Mamdani, B; Mehta, PK; Shansky, RM, 1975) |
| " One hundred patients with severe essential hypertension have been treated with minoxidil for a mean period of 8-4 months in a study involving eleven European centres." | 7.65 | The use of minoxidil in the treatment of severe essential hypertension: a report on 100 patients. ( Brunnberg, FJ; Jacomb, RG, 1976) |
| "Minoxidil is a potent peripheral vasodilator used to treat patients with severe hypertension that is unresponsive to other medications." | 5.27 | Severe hypertrichosis of the external ear canal during minoxidil therapy. ( Berktold, RE; Konior, RJ; Toriumi, DM, 1988) |
| " After 3 and 6 months of maintenance therapy, blood pressures were measured 24 hours after the previous day's dosing to evaluate the persistence of the antihypertensive effect." | 5.27 | The management of severe hypertension with minoxidil in a once-a-day treatment regimen. ( Bayley, A; Fraser, HS; Hassell, TA; Nicholson, GD, 1985) |
| "Minoxidil is a new, effective, investigational antihypertensive drug." | 5.26 | Minoxidil-induced hypertrichosis: treatment with calcium thioglycolate depilatory. ( Aeling, JL; Ball, J; Earhart, RN; Nuss, DD, 1977) |
| "The effects of minoxidil used in combination with propranolol were assessed in the management of moderate hypertension." | 5.05 | Minoxidil in the management of moderate hypertension. ( Alleyne, GA; Nicholson, GD; Valdes, G; Westerman, RL, 1980) |
| "Topical minoxidil has been used for almost 40 years to treat alopecia." | 5.05 | Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review. ( Atanaskova Mesinkovska, N; Juhasz, M; Michelle, L; Muller Ramos, P; Sharma, AN, 2020) |
| "low dose oral minoxidil (OM) is an increasingly used treatment for androgenetic alopecia and other types of hair loss." | 5.05 | Safety of low-dose oral minoxidil treatment for hair loss. A systematic review and pooled-analysis of individual patient data. ( Fernandez-Nieto, D; Jaen-Olasolo, P; Jimenez-Cauhe, J; Moreno-Arrones, OM; Ortega-Quijano, D; Rodrigues-Barata, R; Saceda-Corralo, D; Vaño-Galvan, S, 2020) |
| "Thirteen patients whose hypertension had been resistant to conventional drug therapy, had minoxidil added to their regimen in doses from 5 to 60 mg/day." | 5.04 | Clinical and haemodynamic effects of minoxidil in refractory hypertension. ( Clarkson, AR; Frewin, DB; Jackson, B; Lawrence, JR; Robinson, MA; Wilson, LL; Zacest, R, 1976) |
| "The effect of the new vasodilator, minoxidil, on blood pressure and plasma renin activity was studied in 21 hypertensive patients: 12 patients with essential and 9 with renal hypertension." | 5.04 | The effect of minoxidil on blood pressure and plasma renin activity in patients with essential and renal hypertension. ( Werning, C, 1976) |
| " Twenty patients with severe or moderate hypertension were treated with minoxidil for 284 patient-months." | 5.04 | Treatment of severe and moderate hypertension with minoxidil: experience in twenty-eight patients. ( Dunea, G; Mahurkar, SD; Mamdani, B, 1976) |
| "Minoxidil was first introduced as an antihypertensive medication and the discovery of its common adverse event, hypertrichosis, led to the development of a topical formulation for promoting hair growth." | 5.01 | Minoxidil and its use in hair disorders: a review. ( Leerunyakul, K; Suchonwanit, P; Thammarucha, S, 2019) |
| "Hypertrichosis has been reported more frequently in females than in males who use minoxidil topical solution (MTS) for the treatment of androgenetic alopecia (AGA)." | 4.82 | Hypertrichosis in females applying minoxidil topical solution and in normal controls. ( Dawber, RP; Rundegren, J, 2003) |
| "Hypertrichosis is a well-recognized adverse effect of therapy with either cyclosporine or minoxidil." | 4.78 | Drug-induced hypertrichosis: case report and review of the literature. ( Langnas, AM; Miwa, LJ; Shaefer, MS; Shaw, BW; Stratta, RJ; Wood, RP, 1990) |
| "Minoxidil is an orally active vasodilator for treatment of severe hypertension." | 4.76 | Minoxidil. ( Linas, SL; Nies, AS, 1981) |
| "We report three cases of severe hypertrichosis in healthy infants, who did not present any type of endocrinological pathology and whose parents used topical minoxidil for the treatment of their baldness." | 3.96 | Severe hypertrichosis in infants due to transdermic exposure to 5% and 7% topical minoxidil. ( Arcangeli, F; Delgado Rubio, A; García Del Monte, J; Lotti, T; Rica Echevarría, I, 2020) |
| "Hypertrichosis is a well-recognized adverse effect of therapy with either oral or topical minoxidil." | 3.79 | Long-pulsed Nd:YAG laser in the treatment of facial hypertrichosis during topical minoxidil therapy. ( Ben Hamida, M; Benmously Mlika, R; Dorbani Ben Thabet, I; Hammami, H; Mokhtar, I; Rouatbi, M, 2013) |
| "The mechanism by which minoxidil, an adenosine-triphosphate-sensitive potassium channel opener, induces hypertrichosis remains to be elucidated." | 3.71 | Minoxidil-induced hair growth is mediated by adenosine in cultured dermal papilla cells: possible involvement of sulfonylurea receptor 2B as a target of minoxidil. ( Arase, S; Fukui, K; Li, M; Marubayashi, A; Nakaya, Y, 2001) |
| "Five women affected by androgenetic alopecia developed severe hypertrichosis of the face and limbs after 2-3 months of treatment with 5% topical minoxidil." | 3.69 | Diffuse hypertrichosis during treatment with 5% topical minoxidil. ( Misciali, C; Peluso, AM; Tosti, A; Vincenzi, C, 1997) |
| " Using a simple and convenient once-a-day regimen of minoxidil, nadolol, and chlorthalidone, we treated successfully 30 patients with moderate to severe hypertension." | 3.67 | Minoxidil in a once-a-day step-3 antihypertensive program. ( Alveranga, D; Bazilinski, N; Carroll, HJ; Lazar, I; Oh, MS; Uribarri, J, 1985) |
| "Minoxidil, a potent vasodilator antihypertensive agent, was given to 14 patients with severe hypertension uncontrolled by conventional agents." | 3.66 | Minoxidil therapy for refractory hypertension and chronic renal failure. ( Hammond, JJ; Kirkendall, WM, 1979) |
| "A case of hypertrichosis due to the hypotensive drug minoxidil is described." | 3.66 | Hypertrichosis due to minoxidil. ( Burton, JL; Marshall, A, 1979) |
| "The efficacy and side effects of two potent vasodilatators, namely diazoxide and minoxidil given orally, were compared in 11 patients who had hypertension refractory to conventional drug treatment." | 3.66 | [Comparison of oral diazoxide and minoxidil in refractory hypertension]. ( Glück, Z; Grimm, M; Keusch, G; Meier, A; Minder, I; Reubi, FC; Weidmann, P, 1980) |
| "Minoxidil, a potent peripheral vasodilator, was used concomitantly with other antihypertensive drugs for severe hypertension in three children for 47 to 158 weeks at the dosage of 40 to 50 mg/day." | 3.66 | Rebound hypertension following minoxidil withdrawal. ( Makker, SP; Moorthy, B, 1980) |
| "Minoxidil was used in 25 patients with severe hypertension whose blood pressure (BP) could not be controlled with conventional treatment or who suffered from intolerable side effects during treatment with other drugs." | 3.66 | Clinical experience of long-term treatment with minoxidil in severe arterial hypertension. ( Hagstam, KE; Lundgren, R; Wieslander, J, 1982) |
| " One hundred patients with severe essential hypertension have been treated with minoxidil for a mean period of 8-4 months in a study involving eleven European centres." | 3.65 | The use of minoxidil in the treatment of severe essential hypertension: a report on 100 patients. ( Brunnberg, FJ; Jacomb, RG, 1976) |
| " Propranolol and diuretics were given to prevent reflex tachycardia and fluid retention." | 3.65 | Severe hypertension. Treatment with minoxidil. ( Dunea, G; Mahurkar, SD; Mamdani, B; Mehta, PK; Shansky, RM, 1975) |
| " Systemic adverse effects were infrequent and only 1." | 1.62 | Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. ( Bhoyrul, B; Hermosa-Gelbard, A; Jaén-Olasolo, P; Jerjen, R; Jimenez-Cauhe, J; John, JM; Koh, WL; Lo-Sicco, K; Moreno-Arrones, ÓM; Piraccini, BM; Pirmez, R; Poa, JE; Rodrigues-Barata, R; Rudnicka, L; Saceda-Corralo, D; Salas-Callo, CI; Shapiro, J; Sinclair, R; Starace, M; Tosti, A; Trindade de Carvalho, L; Vañó-Galván, S; Vincenzi, C; Waskiel-Burnat, A; Yin, L; Zamorano, JL, 2021) |
| "Minoxidil is a potent peripheral vasodilator used to treat patients with severe hypertension that is unresponsive to other medications." | 1.27 | Severe hypertrichosis of the external ear canal during minoxidil therapy. ( Berktold, RE; Konior, RJ; Toriumi, DM, 1988) |
| " After 3 and 6 months of maintenance therapy, blood pressures were measured 24 hours after the previous day's dosing to evaluate the persistence of the antihypertensive effect." | 1.27 | The management of severe hypertension with minoxidil in a once-a-day treatment regimen. ( Bayley, A; Fraser, HS; Hassell, TA; Nicholson, GD, 1985) |
| "Minoxidil was administered to 13 patients with arterial hypertension resistant to ordinary antihypertensive drugs and with various degrees of renal failure." | 1.26 | [Treatment of arterial hypertension with minoxidil in renal insufficiency]. ( Cianciaruso, B; Dal Canton, A; Federico, S; Gallo, R; Usberti, M, 1980) |
| "Minoxidil is a new, effective, investigational antihypertensive drug." | 1.26 | Minoxidil-induced hypertrichosis: treatment with calcium thioglycolate depilatory. ( Aeling, JL; Ball, J; Earhart, RN; Nuss, DD, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 40 (58.82) | 18.7374 |
| 1990's | 6 (8.82) | 18.2507 |
| 2000's | 3 (4.41) | 29.6817 |
| 2010's | 6 (8.82) | 24.3611 |
| 2020's | 13 (19.12) | 2.80 |
| Authors | Studies |
|---|---|
| Trüeb, RM | 2 |
| Caballero-Uribe, N | 1 |
| Moussa, A | 2 |
| Kazmi, A | 2 |
| Bokhari, L | 2 |
| Sinclair, RD | 3 |
| Luu, NC | 1 |
| Rezende, HD | 1 |
| Ibraheim, MK | 1 |
| Elsensohn, A | 1 |
| Hauschild, C | 1 |
| Hilliard, A | 1 |
| Dao, H | 1 |
| Suchonwanit, P | 1 |
| Thammarucha, S | 1 |
| Leerunyakul, K | 1 |
| Ohko, K | 1 |
| Nakajima, K | 1 |
| Nakajima, H | 1 |
| Hiraki, Y | 1 |
| Kubota, K | 1 |
| Fukao, T | 1 |
| Miyatake, S | 1 |
| Matsumoto, N | 1 |
| Sano, S | 1 |
| Vañó-Galván, S | 4 |
| Trindade de Carvalho, L | 2 |
| Saceda-Corralo, D | 4 |
| Rodrigues-Barata, R | 4 |
| Kerkemeyer, KL | 1 |
| Hermosa-Gelbard, Á | 3 |
| Moreno-Arrones, ÓM | 4 |
| Jimenez-Cauhe, J | 4 |
| Bhoyrul, B | 2 |
| Sharma, AN | 1 |
| Michelle, L | 1 |
| Juhasz, M | 1 |
| Muller Ramos, P | 2 |
| Atanaskova Mesinkovska, N | 1 |
| Ortega-Quijano, D | 2 |
| Fernandez-Nieto, D | 2 |
| Jaen-Olasolo, P | 3 |
| Rica Echevarría, I | 1 |
| García Del Monte, J | 1 |
| Delgado Rubio, A | 1 |
| Arcangeli, F | 1 |
| Lotti, T | 1 |
| Gil-Redondo, R | 1 |
| Sanabria, B | 1 |
| Vanzela, TN | 1 |
| Miot, HA | 1 |
| Pirmez, R | 1 |
| Koh, WL | 1 |
| Poa, JE | 1 |
| Jerjen, R | 1 |
| John, JM | 1 |
| Salas-Callo, CI | 1 |
| Vincenzi, C | 2 |
| Yin, L | 1 |
| Lo-Sicco, K | 1 |
| Waskiel-Burnat, A | 1 |
| Starace, M | 1 |
| Zamorano, JL | 1 |
| Piraccini, BM | 1 |
| Rudnicka, L | 1 |
| Shapiro, J | 1 |
| Tosti, A | 2 |
| Sinclair, R | 1 |
| Benmously Mlika, R | 1 |
| Ben Hamida, M | 1 |
| Hammami, H | 1 |
| Dorbani Ben Thabet, I | 1 |
| Rouatbi, M | 1 |
| Mokhtar, I | 1 |
| Guerouaz, N | 1 |
| Mohamed, AO | 1 |
| Gargallo, V | 1 |
| Gutierrez, C | 1 |
| Vanaclocha, F | 1 |
| Guerra-Tapia, A | 1 |
| Wolff, H | 1 |
| Dawber, RP | 1 |
| Rundegren, J | 1 |
| Foitzik, K | 1 |
| Paus, R | 1 |
| Linas, SL | 1 |
| Nies, AS | 1 |
| Jackson, RV | 1 |
| Williamson, MM | 1 |
| Seneviratne, B | 1 |
| Gordon, RD | 1 |
| Andersson, O | 1 |
| Sivertsson, R | 1 |
| Javier, R | 1 |
| Dumler, F | 1 |
| Park, JH | 1 |
| Bok, DV | 1 |
| Riley, RW | 1 |
| Levin, NW | 1 |
| Sinaiko, AR | 1 |
| O'Dea, RF | 1 |
| Mirkin, BL | 1 |
| Nicholson, GD | 2 |
| Alleyne, GA | 1 |
| Valdes, G | 1 |
| Westerman, RL | 1 |
| Leshchinskiĭ, PM | 2 |
| Henkes, J | 1 |
| Ribera, M | 1 |
| Ferrándiz, C | 1 |
| Ballestero, A | 1 |
| Wilkin, JK | 1 |
| Kirkendall, WM | 2 |
| Hagstam, KE | 1 |
| Lundgren, R | 1 |
| Wieslander, J | 1 |
| Parker, LN | 1 |
| Lifrak, ET | 1 |
| Odell, WD | 1 |
| Bianchetti, MG | 1 |
| Weidmann, P | 3 |
| Boehringer, K | 1 |
| Link, L | 1 |
| Schiffl, H | 1 |
| Beretta-Piccoli, C | 1 |
| Colombo, JP | 1 |
| Nielsen, PG | 1 |
| Makker, SP | 1 |
| Moorthy, B | 1 |
| Ryckmanns, F | 1 |
| Federico, S | 1 |
| Dal Canton, A | 1 |
| Cianciaruso, B | 1 |
| Gallo, R | 1 |
| Usberti, M | 1 |
| Meier, A | 1 |
| Glück, Z | 1 |
| Keusch, G | 1 |
| Grimm, M | 1 |
| Minder, I | 1 |
| Reubi, FC | 1 |
| González, M | 1 |
| Landa, N | 1 |
| Gardeazabal, J | 1 |
| Calderón, MJ | 1 |
| Bilbao, I | 1 |
| Díaz Pérez, JL | 1 |
| Peluso, AM | 1 |
| Misciali, C | 1 |
| Li, M | 1 |
| Marubayashi, A | 1 |
| Nakaya, Y | 1 |
| Fukui, K | 1 |
| Arase, S | 1 |
| Keusch, GW | 1 |
| Campese, V | 1 |
| Lee, DB | 1 |
| Upham, AT | 1 |
| Massry, SG | 1 |
| Larochelle, P | 1 |
| Hamet, P | 1 |
| Beroniade, V | 1 |
| Kuchel, O | 1 |
| Pierard, GE | 1 |
| Letot, B | 1 |
| Henry, C | 1 |
| Hammond, JJ | 1 |
| Burton, JL | 1 |
| Marshall, A | 1 |
| Thien, T | 1 |
| Huysmans, FT | 1 |
| van Leeuwen, K | 1 |
| Tiggeler, RG | 1 |
| Rosier, JG | 1 |
| Koene, RA | 1 |
| Earhart, RN | 2 |
| Zacest, R | 1 |
| Frewin, DB | 1 |
| Robinson, MA | 1 |
| Wilson, LL | 1 |
| Lawrence, JR | 1 |
| Clarkson, AR | 1 |
| Jackson, B | 1 |
| Werning, C | 1 |
| Dunea, G | 2 |
| Mamdani, B | 2 |
| Mahurkar, SD | 2 |
| Ball, J | 1 |
| Nuss, DD | 1 |
| Aeling, JL | 1 |
| Jacomb, RG | 1 |
| Brunnberg, FJ | 1 |
| Aerenlund Jensen, H | 1 |
| Rasmussen, K | 1 |
| Mosbaek, N | 1 |
| Mehta, PK | 1 |
| Shansky, RM | 1 |
| Herxheimer, A | 1 |
| Young, N | 1 |
| Miwa, LJ | 1 |
| Shaefer, MS | 1 |
| Stratta, RJ | 1 |
| Wood, RP | 1 |
| Langnas, AM | 1 |
| Shaw, BW | 1 |
| Hong, D | 1 |
| Hart, LL | 1 |
| Sever, MS | 1 |
| Sonmez, YE | 1 |
| Kocak, N | 1 |
| Baral, J | 1 |
| Toriumi, DM | 1 |
| Konior, RJ | 1 |
| Berktold, RE | 1 |
| Kaler, SG | 1 |
| Patrinos, ME | 1 |
| Lambert, GH | 1 |
| Myers, TF | 1 |
| Karlman, R | 1 |
| Anderson, CL | 1 |
| Rosa, FW | 1 |
| Idanpaan-Heikkila, J | 1 |
| Asanti, R | 1 |
| Oh, MS | 1 |
| Uribarri, J | 1 |
| Alveranga, D | 1 |
| Bazilinski, N | 1 |
| Lazar, I | 1 |
| Carroll, HJ | 1 |
| Fraser, HS | 1 |
| Hassell, TA | 1 |
| Bayley, A | 1 |
| Klimenko, VS | 1 |
| Lorette, G | 1 |
| Nivet, H | 1 |
| Limas, CJ | 1 |
| Freis, ED | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| International Phase III, Multi Center, Randomized, Double Blind, Placebo and Active Controlled and Parallel Group Clinical Trial to Evaluate the Efficacy and Safety of Oral Minoxidil 1 mg in Female Patients With Androgenetic Alopecia[NCT05888922] | Phase 3 | 520 participants (Anticipated) | Interventional | 2024-03-31 | Not yet recruiting | ||
| Randomised, Crossover Bioavailability Clinical Trial of Oral Minoxidil 1 MG, After Single and Multiple Dose Administration to Healthy Volunteers Under Fasting Conditions.[NCT06015516] | Phase 1 | 14 participants (Anticipated) | Interventional | 2024-02-29 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for minoxidil and Hypertrichosis
| Article | Year |
|---|---|
Minoxidil and its use in hair disorders: a review.
Topics: Animals; Antihypertensive Agents; Hair; Humans; Hypertrichosis; Minoxidil; Molecular Structure; Sulf | 2019 |
Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review.
Topics: Administration, Topical; Alopecia; Alopecia Areata; Female; Humans; Hypertrichosis; Male; Minoxidil; | 2020 |
Safety of low-dose oral minoxidil treatment for hair loss. A systematic review and pooled-analysis of individual patient data.
Topics: Alopecia; Humans; Hypertrichosis; Minoxidil; Treatment Outcome | 2020 |
Drug-induced excess hair growth.
Topics: Adrenal Cortex Hormones; Androgens; Anticonvulsants; Cyclosporine; Dinoprost; ErbB Receptors; Hirsut | 2017 |
Hypertrichosis in females applying minoxidil topical solution and in normal controls.
Topics: Administration, Cutaneous; Adult; Alopecia; Dose-Response Relationship, Drug; Facial Dermatoses; Fem | 2003 |
Minoxidil.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Diuretics; Drug Therapy, Combination; Humans; Hyperten | 1981 |
[Minoxidil: pharmacological properties and use in the clinic as a hypotensive agent].
Topics: Animals; Blood Pressure; Dogs; Humans; Hypertension; Hypertrichosis; Minoxidil; Norepinephrine; Pyri | 1983 |
Minoxidil therapy in refractory hypertension analysis of 155 patients.
Topics: Adult; Animals; Body Weight; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrichosis | 1978 |
Drug-induced hypertrichosis: case report and review of the literature.
Topics: Child; Cyclosporins; Humans; Hypertrichosis; Male; Minoxidil | 1990 |
Topical minoxidil for hair loss in women.
Topics: Administration, Topical; Alopecia Areata; Dose-Response Relationship, Drug; Female; Humans; Hypertri | 1990 |
5 trials available for minoxidil and Hypertrichosis
| Article | Year |
|---|---|
Minoxidil in the management of moderate hypertension.
Topics: Blood Pressure; Drug Therapy, Combination; Humans; Hypertension; Hypertrichosis; Minoxidil; Proprano | 1980 |
Minoxidil in severe hypertension.
Topics: Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertensi | 1978 |
Clinical and haemodynamic effects of minoxidil in refractory hypertension.
Topics: Adult; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Drug Resistance; Female; Headache; | 1976 |
The effect of minoxidil on blood pressure and plasma renin activity in patients with essential and renal hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Edema; Female; Humans; Hypertension; Hyperten | 1976 |
Treatment of severe and moderate hypertension with minoxidil: experience in twenty-eight patients.
Topics: Adult; Clinical Trials as Topic; Edema; Female; Humans; Hydralazine; Hypertension; Hypertrichosis; M | 1976 |
53 other studies available for minoxidil and Hypertrichosis
| Article | Year |
|---|---|
Minoxidil-induced hypertrichosis in a breastfed infant.
Topics: Alopecia; Breast Feeding; Female; Humans; Hypertension; Hypertrichosis; Infant; Minoxidil | 2022 |
Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients.
Topics: Administration, Topical; Alopecia; Anilides; Female; Humans; Hypertrichosis; Minoxidil; Nitriles; Re | 2022 |
Reply to: "Comment on: Bicalutamide Improves Minoxidil-Induced Hypertrichosis in Female Pattern Hair Loss: A Retrospective Review of 35 Patients".
Topics: Administration, Topical; Alopecia; Anilides; Female; Humans; Hypertrichosis; Minoxidil; Nitriles; Re | 2022 |
Comment on "Bicalutamide Improves Minoxidil-Induced Hypertrichosis in Female Pattern Hair Loss: A Retrospective Review of 35 Patients".
Topics: Alopecia; Anilides; Female; Humans; Hypertrichosis; Minoxidil; Nitriles; Retrospective Studies; Tosy | 2022 |
Low dose oral minoxidil and the conundrum of cardiovascular complications.
Topics: Administration, Topical; Alopecia; Antihypertensive Agents; Hair; Humans; Hypertrichosis; Minoxidil | 2023 |
Skin and hair abnormalities of Cantu syndrome: A congenital hypertrichosis due to a genetic alteration mimicking the pharmacological effect of minoxidil.
Topics: Antihypertensive Agents; Biopsy; Cardiomegaly; Child; Child, Preschool; Female; Hair Follicle; Hirsu | 2020 |
Oral minoxidil improves background hair thickness in lichen planopilaris.
Topics: Administration, Oral; Adult; Aged; Alopecia; Female; Hair; Humans; Hypertrichosis; Hypotension, Orth | 2021 |
Severe hypertrichosis in infants due to transdermic exposure to 5% and 7% topical minoxidil.
Topics: Administration, Cutaneous; Administration, Topical; Alopecia; Humans; Hypertrichosis; Infant; Minoxi | 2020 |
Characterization and management of hypertrichosis induced by low-dose oral minoxidil in the treatment of hair loss.
Topics: Adolescent; Adult; Aged; Alopecia; Antihypertensive Agents; Female; Hair Removal; Humans; Hypertrich | 2021 |
Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients.
Topics: Adult; Alopecia; Body Weight; Dermatologic Agents; Headache; Humans; Hypertrichosis; Male; Minoxidil | 2021 |
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema; | 2021 |
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema; | 2021 |
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema; | 2021 |
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Child; Dizziness; Edema; | 2021 |
Long-pulsed Nd:YAG laser in the treatment of facial hypertrichosis during topical minoxidil therapy.
Topics: Administration, Topical; Alopecia Areata; Child; Female; Hair Removal; Humans; Hypertrichosis; Laser | 2013 |
Minoxidil induced hypertrichosis in children.
Topics: Administration, Topical; Alopecia; Child, Preschool; Female; Humans; Hypertrichosis; Minoxidil | 2014 |
Generalized Hypertrichosis Due to Topical Minoxidil.
Topics: Administration, Cutaneous; Adult; Alopecia; Clobetasol; Drug Combinations; Female; Humans; Hypertric | 2015 |
[Minoxidil : From side effects to therapy].
Topics: Alopecia; Dermatology; Evidence-Based Medicine; Humans; Hypertrichosis; Minoxidil; Treatment Outcome | 2016 |
[Regulation of human hair growth and therapeutic options].
Topics: Animals; Apoptosis; Female; Folliculitis; Gonadal Steroid Hormones; Growth Substances; Hair; Hair Fo | 2005 |
Long term minoxidil therapy and renal function, cardiac function, hypertrichosis and blood pressure.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Drug Therapy, Combination; Ede | 1983 |
Renal function and vascular resistance during long-term minoxidil treatment of severe hypertension.
Topics: Blood Pressure; Creatinine; Edema; Glomerular Filtration Rate; Headache; Humans; Hypertension; Hyper | 1980 |
Long-term treatment with minoxidil in patients with severe renal failure.
Topics: Acute Kidney Injury; Adult; Body Weight; Female; Furosemide; Humans; Hypertension; Hypertension, Pul | 1980 |
Clinical response of hypertensive children to long-term minoxidil therapy.
Topics: Antihypertensive Agents; Blood Pressure; Child; Child, Preschool; Female; Growth; Humans; Hypertensi | 1980 |
[Hypertrichosis caused by minoxidil].
Topics: Adult; Female; Humans; Hypertension, Renovascular; Hypertrichosis; Minoxidil; Pyrimidines | 1984 |
Porphyria mimicked during minoxidil therapy.
Topics: Blister; Diagnosis, Differential; Face; Humans; Hypertrichosis; Male; Middle Aged; Minoxidil; Porphy | 1983 |
Clinical experience of long-term treatment with minoxidil in severe arterial hypertension.
Topics: Adult; Aged; Blood Pressure; Creatinine; Electrocardiography; Female; Humans; Hypertension; Hypertri | 1982 |
Lack of a gonadal or adrenal androgenic mechanism for the hypertrichosis produced by diazoxide, phenytoin and minoxidil.
Topics: Adrenal Glands; Androgens; Animals; Diazoxide; Hypertrichosis; In Vitro Techniques; Male; Minoxidil; | 1982 |
Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Creatinine; Electrolytes; Female; Heart Rate; Hormones; Hu | 1982 |
[Minoxidil and hypertrichosis].
Topics: Adult; Female; Humans; Hypertrichosis; Minoxidil; Pyrimidines | 1981 |
Rebound hypertension following minoxidil withdrawal.
Topics: Adolescent; Child; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrichosis; Male; Mi | 1980 |
[Hypertrichosis caused by minoxidil].
Topics: Adolescent; Humans; Hypertrichosis; Male; Minoxidil; Pyrimidines | 1980 |
[Treatment of arterial hypertension with minoxidil in renal insufficiency].
Topics: Adult; Child, Preschool; Female; Humans; Hypertension, Renal; Hypertrichosis; Kidney Failure, Chroni | 1980 |
[Comparison of oral diazoxide and minoxidil in refractory hypertension].
Topics: Blood Glucose; Blood Pressure; Body Weight; Diazoxide; Diuretics; Drug Therapy, Combination; Electro | 1980 |
Generalized hypertrichosis after treatment with topical minoxidil.
Topics: Administration, Topical; Adolescent; Female; Humans; Hypertrichosis; Minoxidil | 1994 |
Diffuse hypertrichosis during treatment with 5% topical minoxidil.
Topics: Administration, Cutaneous; Adolescent; Adult; Alopecia; Female; Humans; Hypertrichosis; Middle Aged; | 1997 |
Minoxidil-induced hair growth is mediated by adenosine in cultured dermal papilla cells: possible involvement of sulfonylurea receptor 2B as a target of minoxidil.
Topics: Adenosine; Adenosine Triphosphate; ATP-Binding Cassette Transporters; Calcium; Cells, Cultured; Derm | 2001 |
[Fluffy hypertrichosis induced by minoxidil].
Topics: Female; Humans; Hypertrichosis; Middle Aged; Minoxidil; Pyrimidines; Skin | 1979 |
Minoxidil therapy for refractory hypertension and chronic renal failure.
Topics: Adolescent; Adult; Creatinine; Female; Humans; Hypertension; Hypertrichosis; Kidney; Kidney Failure, | 1979 |
Hypertrichosis due to minoxidil.
Topics: Humans; Hypertension; Hypertrichosis; Male; Middle Aged; Minoxidil; Pyrimidines | 1979 |
Treatment of moderate and severe hypertension with minoxidil.
Topics: Adult; Chlorthalidone; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Hyp | 1979 |
Depilation treatment of hypertrichosis.
Topics: Female; Hair Removal; Humans; Hypertrichosis; Minoxidil | 1978 |
Minoxidil-induced hypertrichosis: treatment with calcium thioglycolate depilatory.
Topics: Female; Hair Removal; Humans; Hypertension; Hypertension, Renal; Hypertrichosis; Lupus Erythematosus | 1977 |
The use of minoxidil in the treatment of severe essential hypertension: a report on 100 patients.
Topics: Electrocardiography; Female; Humans; Hypertension; Hypertrichosis; Male; Middle Aged; Minoxidil; Pyr | 1976 |
Clinical and haemodynamic study of minoxidil in moderately hypertensive patients.
Topics: Aged; Female; Humans; Hypertension; Hypertrichosis; Male; Middle Aged; Minoxidil; Pyrimidines | 1976 |
Severe hypertension. Treatment with minoxidil.
Topics: Adult; Black People; Drug Evaluation; Edema; Female; Follow-Up Studies; Guanethidine; Humans; Hypert | 1975 |
Duty to warn about likely adverse effects.
Topics: Female; Humans; Hypertension; Hypertrichosis; Malpractice; Middle Aged; Minoxidil; Patient Education | 1990 |
Limited use of minoxidil in renal transplant recipients because of the additive side-effects of cyclosporine on hypertrichosis.
Topics: Cyclosporins; Drug Interactions; Female; Humans; Hypertension; Hypertrichosis; Kidney Transplantatio | 1990 |
Minoxidil and tail-like effect.
Topics: Alopecia Areata; Child, Preschool; Female; Humans; Hypertrichosis; Minoxidil | 1989 |
Severe hypertrichosis of the external ear canal during minoxidil therapy.
Topics: Ear, Middle; Hearing Loss, Bilateral; Humans; Hypertrichosis; Male; Middle Aged; Minoxidil; Otitis E | 1988 |
Hypertrichosis and congenital anomalies associated with maternal use of minoxidil.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Captopril; Female; Humans; Hypertension; Hyper | 1987 |
Fetal minoxidil exposure.
Topics: Abnormalities, Multiple; Female; Humans; Hypertension; Hypertrichosis; Infant, Newborn; Minoxidil; P | 1987 |
Minoxidil in a once-a-day step-3 antihypertensive program.
Topics: Chlorthalidone; Drug Therapy, Combination; Edema; Female; Humans; Hypertension; Hypertrichosis; Male | 1985 |
The management of severe hypertension with minoxidil in a once-a-day treatment regimen.
Topics: Adult; Aged; Chlorthalidone; Creatinine; Drug Therapy, Combination; Edema; Female; Humans; Hypertens | 1985 |
[Results of prolonged use of minoxidil in patients with stable and malignant arterial hypertension].
Topics: Adult; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Hypertension, Malignant; | 1985 |
[Diffuse hypertrichosis caused by minoxidil in a 2-and-a-half-year-old child].
Topics: Child, Preschool; Humans; Hypertrichosis; Male; Minoxidil | 1985 |
Minoxidil in severe hypertension with renal failure. Effect of its addition to conventional antihypertensive drugs.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Evaluation Studies as Topic; Female; Follow-Up Studi | 1973 |